Hutchin Hill Capital’s DexCom DXCM Stock Holding History

Hutchin Hill Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-26,400	Closed	-$541K	–	660
2015 Q4	$541K	Buy	+26,400	New	+$549K	0.01%	510
2015 Q2	–	Sell	-25,200	Closed	-$393K	–	692
2015 Q1	$393K	Sell	25,200 -32,308	-56%	-$488K	0.01%	569
2014 Q4	$791K	Sell	57,508 -1,808	-3%	-$22.1K	0.03%	373
2014 Q3	$593K	Buy	+59,316	New	+$606K	0.02%	452

Other funds holding DXCM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Hutchin Hill Capital's DXCM Position: Q1 2016 in Review

Hutchin Hill Capital sold out of DexCom (DXCM) in Q1 2016, closing a stake of 26,400 shares — an estimated $541K sold.

Hutchin Hill Capital first reported a position in DXCM in Q3 2014 and held it in 4 quarters. The position peaked at $791K in Q4 2014. 264 funds tracked by Wall St. Rank hold DXCM as of Q1 2016.

Hutchin Hill Capital reported no remaining DexCom position as of Q1 2016 after selling out during the quarter.
Hutchin Hill Capital sold 26,400 DexCom shares in Q1 2016, an estimated $541K.
Hutchin Hill Capital first reported a position in DexCom in Q3 2014 and held it in 4 quarters.
Hutchin Hill Capital's DexCom position peaked at $791K in Q4 2014.
264 funds tracked by Wall St. Rank held DexCom as of Q1 2016.

Based on Hutchin Hill Capital's 13F filing for Q1 2016, filed 16 May 2016.